Nucleolin is important for Epstein-Barr virus nuclear antigen 1-mediated episome binding, maintenance, and transcription

Proceedings of the National Academy of Sciences of the United States of America
Ya-Lin ChenChih-wen Peng

Abstract

Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1) is essential for EBV episome maintenance, replication, and transcription. These effects are mediated by EBNA1 binding to cognate oriP DNA, which comprise 20 imperfect copies of a 30-bp dyad symmetry enhancer and an origin for DNA replication. To identify cell proteins essential for these EBNA1 functions, EBNA1 associated cell proteins were immune precipitated and analyzed by liquid chromatography-tandem mass spectrometry. Nucleolin (NCL) was identified to be EBNA1 associated. EBNA1's N-terminal 100 aa and NCL's RNA-binding domains were critical for EBNA1/NCL interaction. Lentivirus shRNA-mediated NCL depletion substantially reduced EBNA1 recruitment to oriP DNA, EBNA1-dependent transcription of an EBV oriP luciferase reporter, and EBV genome maintenance in lymphoblastoid cell lines. NCL RNA-binding domain K429 was critical for ATP and EBNA1 binding. NCL overexpression increased EBNA1 binding to oriP and transcription, whereas NCL K429A was deficient. Moreover, NCL silencing impaired lymphoblastoid cell line growth. These experiments reveal a surprisingly critical role for NCL K429 in EBNA1 episome maintenance and transcription, which may be a target for therapeutic intervention.

References

Apr 1, 1996·European Journal of Biochemistry·Y P LiH Busch
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·L A HanakahiN Maizels
Feb 8, 2000·The Journal of Biological Chemistry·G G YingJ Golay
May 9, 2000·Journal of Virology·D F Ceccarelli, L Frappier
Oct 23, 2002·The Journal of Experimental Medicine·Edgar GrinsteinHans-Dieter Royer
Apr 23, 2003·Chromosoma·Gregory J Pellar, Patrick J DiMario
May 12, 2006·Current Opinion in Cell Biology·Ivan RaskaDusan Cmarko
May 16, 2006·The Journal of Biological Chemistry·Edgar GrinsteinPeter Wernet
Jun 27, 2006·EMBO Reports·Constandache AtanasiuPaul M Lieberman
Sep 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Markus AltmannWolfgang Hammerschmidt
Dec 13, 2006·Trends in Cell Biology·Fabien Mongelard, Philippe Bouvet
Apr 6, 2007·Journal of Virology·Latasha DayPaul M Lieberman
Jul 16, 2008·The Journal of Cell Biology·Pier Paolo Di Fiore
Oct 17, 2008·Journal of Virology·Ammy LinLori Frappier
Oct 8, 2011·Communicative & Integrative Biology·Marjan M TajrishiNarendra Tuteja
Jan 10, 2012·Biochemical and Biophysical Research Communications·Ya-Lin ChenChih-Wen Peng
Aug 23, 2012·The Journal of Biological Chemistry·Dongyun ZhangChuanshu Huang
Oct 4, 2012·Current Opinion in Virology·Lori Frappier
Apr 24, 2013·The Journal of Experimental Medicine·Flavia PichiorriCarlo M Croce

❮ Previous
Next ❯

Citations

Feb 10, 2016·Proceedings of the National Academy of Sciences of the United States of America·Chih-Lung ShenChih-Wen Peng
Jun 5, 2015·Cellular Microbiology·Stephen M Rawlinson, Gregory W Moseley
Feb 6, 2016·PLoS Pathogens·Matthew R HarterJikui Song
Dec 4, 2019·The Journal of General Virology·Dandan DongGuangqing Liu
Feb 15, 2020·Nature Communications·Kyoung-Dong KimPaul M Lieberman
Dec 23, 2016·Biochimica Et Biophysica Acta. General Subjects·Paula J BatesJohn O Trent
Oct 19, 2019·Trends in Microbiology·Alessandra De LeoPaul M Lieberman

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.